Factors Influencing Intention to Obtain the HPV Vaccine in South East Asian and Western Pacific Regions: A Systematic Review and Meta-analysis

Overview

Journal Sci Rep

Specialty Science

Date 2018 Feb 28

PMID 29483541

Citations 30

Authors

Diviya Santhanes

Che Pui Yong

Yan Ye Yap

Pui San Saw

Nathorn Chaiyakunapruk

Tahir Mehmood Khan

Affiliations

Soon will be listed here.

Abstract

Since licensing in 2006, there has been poor uptake of the HPV vaccine among the targeted population in the South East Asia Region (SEAR) and Western Pacific Region (WPR). A systematic review was conducted to identify the studies exploring the relationship between factors and intention for HPV vaccination among women in SEAR and WPR countries. Nineteen studies were identified as suitable for qualitative synthesis, and three as suitable for meta-analysis. Most women had a positive intention to have an HPV vaccine (range 57%-85%). Having a positive intention to vaccinate was significantly higher among women not aware of HPV infection (OR: 1.34, 95% CI: 1.02-1.76) and HPV vaccine (OR: 1.57, 95% CI: 1.26-1.96). Lower knowledge level and less confidence in safety and efficacy of the vaccine, negatively affected intention to vaccinate. Perceiving the vaccine to be expensive, low perception of contracting HPV infection and cervical cancer, and lack of concrete recommendations from healthcare providers also negatively affected intention to vaccinate. This review suggests the decision-making processes of women in SEAR and WPR is influenced by the cost of vaccination, perceived efficacy and safety of vaccine, provision of information on vaccination, and the awareness about HPV infection and the HPV vaccine.

Citing Articles

Knowledge, attitude, and reasons for non-uptake of human papilloma virus vaccination among nursing students.

Chauhan S, Tiwari S, Dubey V, Tripathi P, Pandey P, Singh A BMC Med. 2025; 23(1):35.

PMID: 39838402 PMC: 11752721. DOI: 10.1186/s12916-025-03874-w.

Socioeconomic/health-related factors associated with HPV vaccination initiation/completion among females of paediatric age: A systematic review with meta-analysis.

Okoli G, Grossman Moon A, Soos A, Neilson C, Kimmel Supron H, Etsell K Public Health Pract (Oxf). 2025; 9():100562.

PMID: 39802391 PMC: 11721234. DOI: 10.1016/j.puhip.2024.100562.

Awareness and acceptance of human papillomavirus vaccine in the Middle East: A systematic review, meta-analysis, and meta-regression of 159 studies.

Gulle B, Kiran P, Celik S, Varol Z, Siyve N, Emecen A Epidemiol Infect. 2024; 152:e165.

PMID: 39655623 PMC: 11696605. DOI: 10.1017/S0950268824001596.

Prevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis.

Maamor N, Muhamad N, Mohd Dali N, Leman F, Rosli I, Tengku Bahrudin Shah T PLoS One. 2024; 19(10):e0302379.

PMID: 39446774 PMC: 11500859. DOI: 10.1371/journal.pone.0302379.

Cervical cancer in Thailand: 2023 update.

Wongpratate M, Bumrungthai S Obstet Gynecol Sci. 2024; 67(3):261-269.

PMID: 38528826 PMC: 11099091. DOI: 10.5468/ogs.23277.

References

McKee C, Bohannon K . Exploring the Reasons Behind Parental Refusal of Vaccines. J Pediatr Pharmacol Ther. 2016; 21(2):104-9. PMC: 4869767. DOI: 10.5863/1551-6776-21.2.104. View

Leval A, Herweijer E, Ploner A, Eloranta S, Simard J, Dillner J . Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst. 2013; 105(7):469-74. PMC: 3614506. DOI: 10.1093/jnci/djt032. View

Sam I, Wong L, Rampal S, Leong Y, Pang C, Tai Y . Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolesc Health. 2009; 44(6):610-2. DOI: 10.1016/j.jadohealth.2008.11.014. View

Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Matsuzaki S, Kobayashi E . Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan. Int J Clin Oncol. 2015; 21(1):53-8. DOI: 10.1007/s10147-015-0869-5. View

Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch F . Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016; 4(7):e453-63. DOI: 10.1016/S2214-109X(16)30099-7. View

Hendry M, Lewis R, Clements A, Damery S, Wilkinson C . "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination. Vaccine. 2013; 31(45):5152-67. DOI: 10.1016/j.vaccine.2013.08.091. View

Juntasopeepun P, Davidson P, Suwan N, Phianmongkhol Y, Srisomboon J . Human papillomavirus vaccination intention among young women in Thailand. Asian Pac J Cancer Prev. 2012; 12(12):3213-9. View

Cui Y, Baldwin S, Wiley D, Fielding J . Human papillomavirus vaccine among adult women: disparities in awareness and acceptance. Am J Prev Med. 2010; 39(6):559-63. DOI: 10.1016/j.amepre.2010.08.001. View

Wong L . Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural southeast Asian women. Int J Behav Med. 2010; 18(2):105-11. DOI: 10.1007/s12529-010-9104-y. View

10.

Charakorn C, Rattanasiri S, Lertkhachonsuk A, Thanapprapasr D, Chittithaworn S, Wilailak S . Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women. Asia Pac J Clin Oncol. 2011; 7(2):160-7. DOI: 10.1111/j.1743-7563.2011.01392.x. View

11.

Kessels S, Marshall H, Watson M, Braunack-Mayer A, Reuzel R, Tooher R . Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012; 30(24):3546-56. DOI: 10.1016/j.vaccine.2012.03.063. View

12.

Marlow L, Wardle J, Waller J . Attitudes to HPV vaccination among ethnic minority mothers in the UK: an exploratory qualitative study. Hum Vaccin. 2009; 5(2):105-10. DOI: 10.4161/hv.5.2.7368. View

13.

Ports K, Reddy D, Rameshbabu A . Barriers and facilitators to HPV vaccination: perspectives from Malawian women. Women Health. 2013; 53(6):630-45. PMC: 4681389. DOI: 10.1080/03630242.2013.809046. View

14.

Brewer N, Fazekas K . Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007; 45(2-3):107-14. DOI: 10.1016/j.ypmed.2007.05.013. View

15.

Johnson D, Bhatta M, Gurung S, Aryal S, Lhaki P, Shrestha S . Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities. Asian Pac J Cancer Prev. 2014; 15(19):8287-93. DOI: 10.7314/apjcp.2014.15.19.8287. View

16.

Kruiroongroj S, Chaikledkaew U, Thavorncharoensap M . Knowledge, acceptance, and willingness to pay for human papilloma virus (HPV) vaccination among female parents in Thailand. Asian Pac J Cancer Prev. 2014; 15(13):5469-74. DOI: 10.7314/apjcp.2014.15.13.5469. View

17.

Santhanes D, Wong C, Yap Y, San S, Chaiyakunapruk N, Khan T . Factors involved in human papillomavirus (HPV) vaccine hesitancy among women in the South-East Asian Region (SEAR) and Western Pacific Region (WPR): A scoping review. Hum Vaccin Immunother. 2017; 14(1):124-133. PMC: 5791566. DOI: 10.1080/21645515.2017.1381811. View

18.

Kang H, Moneyham L . Attitudes toward and intention to receive the human papilloma virus (HPV) vaccination and intention to use condoms among female Korean college students. Vaccine. 2009; 28(3):811-6. DOI: 10.1016/j.vaccine.2009.10.052. View

19.

Katahoire R, Jitta J, Kivumbi G, Murokora D, Arube W, Siu G . An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health. 2009; 12(3):159-72. View

20.

Choi H, Leung G, Woo P, Jit M, Wu J . Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: a survey of mothers and adolescents. Vaccine. 2013; 32(1):78-84. DOI: 10.1016/j.vaccine.2013.10.068. View